CCCC
NASDAQStockC4 Therapeutics, Inc.
$2.73-0.02 (-0.73%)
52-Week Range
$1.10
$3.59
Key Stats
Market Cap
202.3M
P/E Ratio
—
Dividend Yield
—
Beta
2.94
Volume
1.5M
Avg Volume
3.7M
Performance
1M
+45.50%
3M
+13.17%
6M
-19.35%
YTD
+42.49%
1Y
+31.58%
3Y
-33.89%
5Y
-93.70%
Price Chart
ETF Exposure
CCCC is held by 19 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.53% |
| IWC | iShares Micro-Cap ETF | 0.04% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.03% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.02% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.02% |
| IBB | iShares Biotechnology ETF | 0.02% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.01% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.01% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
About CCCC ETF Exposure
C4 Therapeutics, Inc. (CCCC) is held by 19 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 202.3M, CCCC is a widely held institutional stock. The stock currently trades at $2.73. Investors can gain exposure to CCCC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CCCC, sorted by portfolio weight.